Ausgabe 2/2012
Inhalt (42 Artikel)
Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors
César Fernández-de-las-Peñas, Carolina Fernández-Lao, Irene Cantarero-Villanueva, Silvia Ambite-Quesada, Inés Rivas-Martínez, Rosario del Moral-Avila, Manuel Arroyo-Morales
Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors
N. Lynn Henry, Daniel J. Clauw
Effect of anti-DR5 and chemotherapy on basal-like breast cancer
Patsy G. Oliver, Albert F. LoBuglio, Tong Zhou, Andres Forero, Hyunki Kim, Kurt R. Zinn, Guihua Zhai, Yufeng Li, Choo H. Lee, Donald J. Buchsbaum
Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer
Emi Tokuda, Yuko Seino, Atsushi Arakawa, Mitsue Saito, Fujio Kasumi, Shin-ichi Hayashi, Yuri Yamaguchi
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity
Angelina I. Londoño-Joshi, Patsy G. Oliver, Yufeng Li, Choo Hyung Lee, Andres Forero-Torres, Albert F. LoBuglio, Donald J. Buchsbaum
C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth
Margaret Flowers, Gemma Fabriás, Antonio Delgado, Josefina Casas, Jose Luis Abad, Myles C. Cabot
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
Osvaldo Pontiggia, Rocio Sampayo, Diego Raffo, Andrea Motter, Ren Xu, Mina J. Bissell, Elisa Bal de Kier Joffé, Marina Simian
The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells
Yi Ma, Xiaomeng Hao, Sheng Zhang, Jin Zhang
The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells
Chunyu Wang, Julie Ann Mayer, Abhijit Mazumdar, Powel H. Brown
Vascular proliferation is a prognostic factor in breast cancer
Jarle B. Arnes, Ingunn M. Stefansson, Oddbjørn Straume, Jan P. Baak, Per E. Lønning, William D. Foulkes, Lars A. Akslen
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors
Carmine Fedele, Gennaro Riccio, Carmela Coppola, Antonio Barbieri, Maria Gaia Monti, Claudio Arra, Carlo G. Tocchetti, Giuseppe D’Alessio, Nicola Maurea, Claudia De Lorenzo
Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice
Penelope D. Ottewell, Hannah K. Brown, Mark Jones, Thea L. Rogers, Simon S. Cross, Nicola J. Brown, Robert E. Coleman, Ingunn Holen
Quality of life among Egyptian women with breast cancer after sparing mastectomy and immediate autologous breast reconstruction: a comparative study
Adel Denewer, Omar Farouk, Sherif Kotb, Ahmed Setit, Seham Abd El-khalek, Mosab Shetiwy
A comparison of quality of life of early breast cancer patients treated with accelerated partial breast irradiation versus whole breast irradiation in China
Zhen-Yu He, Qin Tong, San-Gang Wu, Feng-Yan Li, Huan-Xin Lin, Xun-Xing Guan
Improving communication of breast cancer recurrence risk
Noel T. Brewer, Alice R. Richman, Jessica T. DeFrank, Valerie F. Reyna, Lisa A. Carey
IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways
Tania Benatar, Wenyi Yang, Yutaka Amemiya, Valentina Evdokimova, Harriette Kahn, Claire Holloway, Arun Seth
EpCAM expression is an indicator of recurrence in basal-like breast cancer
Ayodeji J. Agboola, E. Claire Paish, Emad A. Rakha, Desmond G. Powe, R. Douglas Macmillan, Ian O. Ellis, Andrew R. Green
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours
Karolina Holm, Johan Staaf, Göran Jönsson, Johan Vallon-Christersson, Haukur Gunnarsson, Adalgeir Arason, Linda Magnusson, Rosa B. Barkardottir, Cecilia Hegardt, Markus Ringnér, Åke Borg
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts
P. Cottu, E. Marangoni, F. Assayag, P. de Cremoux, A. Vincent-Salomon, Ch. Guyader, L. de Plater, C. Elbaz, N. Karboul, J. J. Fontaine, S. Chateau-Joubert, P. Boudou-Rouquette, S. Alran, V. Dangles-Marie, D. Gentien, M.-F. Poupon, D. Decaudin
GRB7 is required for triple-negative breast cancer cell invasion and survival
Orsi Giricz, Verónica Calvo, Stephanie C. Pero, David N. Krag, Joseph A. Sparano, Paraic A. Kenny
Life stage differences in mammary gland gene expression profile in non-human primates
Petra Stute, Sonja Sielker, Charles E. Wood, Thomas C. Register, Cynthia J. Lees, Fitriya N. Dewi, J. Koudy Williams, Janice D. Wagner, Ulrich Stefenelli, J. Mark Cline
Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells
M. Luísa Dória, Zita Cotrim, Bárbara Macedo, Cláudia Simões, Pedro Domingues, Luisa Helguero, M. Rosário Domingues
Epigenetic silencing of the tumor suppressor klotho in human breast cancer
Tami Rubinek, Michal Shulman, Shira Israeli, Shikha Bose, Ayelet Avraham, Adi Zundelevich, Ella Evron, Einav Nili Gal-Yam, Bella Kaufman, Ido Wolf
Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy
Alexandre Peres, Emmanuel Barranger, Véronique Becette, Alain Boudinet, Jean-Marc Guinebretiere, Pascal Cherel
Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial
Sharon L. Kilbreath, Kathryn M. Refshauge, Jane M. Beith, Leigh C. Ward, MiJoung Lee, Judy M. Simpson, Ross Hansen
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score
Alan H. B. Wu, Wendy Lorizio, Simone Tchu, Kara Lynch, Roy Gerona, Wuyang Ji, Weiming Ruan, Kathryn J. Ruddy, Stephen D. Desantis, Harold J. Burstein, Elad Ziv
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results
Shunji Takahashi, Takuji Iwase, Norio Kohno, Takashi Ishikawa, Tetsuya Taguchi, Masato Takahashi, Jun Horiguchi, Seigo Nakamura, Yasuo Hozumi, Masao Fukunaga, Shinzaburo Noguchi
Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer?
Tanya S. Berrang, Mary Lesperance, Pauline T. Truong, Caroline Walter, Allen H. Hayashi, Ivo A. Olivotto
Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence
Yi Ling Teo, Manit Saetaew, Suthan Chanthawong, Yoon Sim Yap, Eric Chun Yong Chan, Han Kiat Ho, Alexandre Chan
Invasive lobular breast cancer: subtypes and outcome
Monica Iorfida, Eugenio Maiorano, Enrico Orvieto, Patrick Maisonneuve, Luca Bottiglieri, Nicole Rotmensz, Emilia Montagna, Silvia Dellapasqua, Paolo Veronesi, Viviana Galimberti, Alberto Luini, Aron Goldhirsch, Marco Colleoni, Giuseppe Viale
Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene
Michelle G. Rath, Farnoosh Fathali-Zadeh, Anne Langheinz, Sandrine Tchatchou, Theda Voigtländer, Jörg Heil, Michael Golatta, Sarah Schott, Teresa Drasseck, Anne Behnecke, Anna-Lena Burgemeister, Christina Evers, Peter Bugert, Hans Junkermann, Andreas Schneeweiss, Claus R. Bartram, Christof Sohn, Christian Sutter, Barbara Burwinkel
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening
Kelly A. Metcalfe, Nida Mian, Melissa Enmore, Aletta Poll, Marcia Llacuachaqui, Sonia Nanda, Ping Sun, Kevin S. Hughes, Steven A. Narod
Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes
Byeong-Woo Park, Seho Park, Hyung Seok Park, Ja Seung Koo, Woo Ick Yang, Jun Sang Lee, Hyewon Hwang, Seung Il Kim, Kyong Sik Lee
Health-related quality of life in male breast cancer patients
Christoph Kowalski, Petra Steffen, Nicole Ernstmann, Rachel Wuerstlein, Nadia Harbeck, Holger Pfaff
Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan
Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi
The single-nucleotide polymorphisms +936 C/T VEGF and −710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population
Patricia Rodrigues, Jessica Furriol, Eduardo Tormo, Sandra Ballester, Ana Lluch, Pilar Eroles
Increased diagnosis and detection rates of carcinoma in situ of the breast
J. A. Glover, F. J. Bannon, C. M. Hughes, M. M. Cantwell, H. Comber, A. Gavin, S. Deady, L. J. Murray
Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Catherine A. McCarty, Douglas J. Reding, John Commins, Craig Williams, Meredith Yeager, James K. Burmester, Catherine Schairer, Regina G. Ziegler
Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen
N. G. L. Jager, H. Rosing, S. C. Linn, J. H. M. Schellens, J. H. Beijnen
Mesothelin, a novel immunotherapy target for triple negative breast cancer
Julia Tchou, Liang-Chuan Wang, Ben Selven, Hongtao Zhang, Jose Conejo-Garcia, Hossein Borghaei, Michael Kalos, Robert H. Vondeheide, Steven M. Albelda, Carl H. June, Paul J. Zhang
The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians
Irene Catucci, Paolo Verderio, Sara Pizzamiglio, Loris Bernard, Valentina Dall’olio, Domenico Sardella, Fernando Ravagnani, Laura Galastri, Monica Barile, Bernard Peissel, Daniela Zaffaroni, Siranoush Manoukian, Paolo Radice, Paolo Peterlongo
Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women
Martin Mateju, Petra Kleiblova, Zdenek Kleibl, Marketa Janatova, Jana Soukupova, Ivana Ticha, Jan Novotny, Petr Pohlreich